Jiefu Wang

700 total citations
32 papers, 418 citations indexed

About

Jiefu Wang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Jiefu Wang has authored 32 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Surgery. Recurrent topics in Jiefu Wang's work include Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Jiefu Wang is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Jiefu Wang collaborates with scholars based in China, United States and Canada. Jiefu Wang's co-authors include Zhan Yang, Guang Yang, Jiansheng Guo, Jia Liu, Cheng Yang, Ming Li, Junfeng Wang, Zhiwen Tang, Yue Sun and Mingming Wei and has published in prestigious journals such as ACS Nano, Gut and World Journal of Gastroenterology.

In The Last Decade

Jiefu Wang

30 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiefu Wang China	11	277	141	127	46	39	32	418
Yuanfei Shi China	11	375 1.4×	97 0.7×	160 1.3×	43 0.9×	30 0.8×	26	488
Juan Lin China	9	235 0.8×	81 0.6×	111 0.9×	24 0.5×	38 1.0×	14	365
Eunjin Bae South Korea	12	226 0.8×	91 0.6×	68 0.5×	29 0.6×	45 1.2×	16	337
Anna Elisabetta Brunetti Italy	10	138 0.5×	175 1.2×	60 0.5×	37 0.8×	45 1.2×	18	336
Elisa Paolicchi Italy	9	335 1.2×	161 1.1×	146 1.1×	30 0.7×	55 1.4×	14	483
Kati Servan Germany	6	224 0.8×	119 0.8×	105 0.8×	49 1.1×	24 0.6×	6	389
Linglong Yin China	10	342 1.2×	144 1.0×	122 1.0×	40 0.9×	85 2.2×	17	469
Hirokazu Uetsuka Japan	10	259 0.9×	110 0.8×	80 0.6×	25 0.5×	43 1.1×	21	423
Kevin S. Quackenbush United States	12	228 0.8×	219 1.6×	112 0.9×	47 1.0×	71 1.8×	17	423

Countries citing papers authored by Jiefu Wang

Since Specialization

Citations

This map shows the geographic impact of Jiefu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiefu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiefu Wang more than expected).

Fields of papers citing papers by Jiefu Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiefu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiefu Wang. The network helps show where Jiefu Wang may publish in the future.

Co-authorship network of co-authors of Jiefu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiefu Wang. A scholar is included among the top collaborators of Jiefu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiefu Wang. Jiefu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jiefu, Zhicheng Gong, Jia Liu, et al.. (2025). Fc fragment of IgG binding protein suppresses tumor growth by stabilizing wild type P53 in colorectal cancer cells. BMC Cancer. 25(1). 507–507. 1 indexed citations

Wang, Wenpeng, et al.. (2025). Comparing robot-assisted vs. laparoscopic proctectomy for rectal cancer surgical and oncological outcomes. Frontiers in Surgery. 12. 1628649–1628649. 1 indexed citations

Wang, Jiefu, Ning Wang, Mengmeng Wang, et al.. (2025). Discovery of novel sitolactone derivative leading to PANoptosis and differentiation of acute myeloid leukemia cells. European Journal of Medicinal Chemistry. 288. 117360–117360. 1 indexed citations

Liu, Hui, He Zhang, Zhaosong Wang, et al.. (2025). Fructose drives colorectal cancer progression by regulating crosstalk between cancer-associated fibroblasts and tumour cells. Gut. 75(3). 548–562.

Han, Ziyu, Chunfeng Xie, Ning Liu, et al.. (2025). Natural products harboring Michael receptors: A focus on targeting cancer stem cells. European Journal of Medicinal Chemistry. 302. 118280–118280.

Wang, Wenpeng, et al.. (2025). Comparative study of robotic-assisted vs. laparoscopic surgery for colorectal cancer: a single-center experience. Frontiers in Oncology. 14. 1507323–1507323. 2 indexed citations

Knox, Kennady, Devon Jeltema, Nicole Dobbs, et al.. (2025). Dynamic STING repression orchestrates immune cell development and function. Science Immunology. 10(105). eado9933–eado9933. 5 indexed citations

Liu, Yulin, Yan Zhang, Zixuan Zhang, et al.. (2024). Design, synthesis and evaluation of a pyrazolo[3,4-d]pyrimidine derivative as a novel and potent TGFβ1R1 inhibitor. European Journal of Medicinal Chemistry. 271. 116395–116395. 6 indexed citations

Wang, Jiefu, et al.. (2024). Comparison of the measurement properties and consistency between the EQ-5D-3L and EQ-5D-Y-3L in adolescents aged 15–17 in China. Health and Quality of Life Outcomes. 22(1). 59–59. 2 indexed citations

10.

Wang, Jiefu, et al.. (2024). Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma. World Journal of Gastroenterology. 30(6). 565–578. 1 indexed citations

11.

Huang, Ziqi, Mengmeng Wang, Mei Li, et al.. (2024). Molecular glue triggers degradation of PHGDH by enhancing the interaction between DDB1 and PHGDH. Acta Pharmaceutica Sinica B. 14(9). 4001–4013. 6 indexed citations

12.

Liu, Yulin, Xuan Wang, Lan Ma, et al.. (2023). Discovery of novel and bioavailable histone deacetylases and cyclin-dependent kinases dual inhibitor to impair the stemness of leukemia cells. European Journal of Medicinal Chemistry. 249. 115140–115140. 6 indexed citations

13.

Hou, Fei, Yuhong Yao, Xinqiang Liu, et al.. (2023). Design and discovery of new selective and potent VEGF receptor 2 tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry. 91. 117404–117404. 5 indexed citations

14.

Liu, Kai, et al.. (2021). Prognosis model of colorectal cancer patients based on NOTCH3, KMT2C, and CREBBP mutations. Journal of Gastrointestinal Oncology. 12(1). 79–88. 10 indexed citations

15.

Wei, Mingming, Rui Zhao, Yuting Cao, et al.. (2020). First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivo. European Journal of Medicinal Chemistry. 209. 112903–112903. 77 indexed citations

16.

Wang, Cui, et al.. (2020). Nomogram model characterized by mutant genes and clinical indexes to identify high-risk patients with stage III/IV colorectal cancer. Journal of Gastrointestinal Oncology. 11(6). 1214–1223. 2 indexed citations

17.

Pang, Qingsong, Dong Qian, Jingjing Cheng, et al.. (2016). PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis. OncoTargets and Therapy. Volume 9. 4821–4831. 8 indexed citations

18.

Zhu, Zhenqi, Kaifeng Wang, Jian Zhou, et al.. (2015). Topping-off technique prevents aggravation of degeneration of adjacent segment fusion revealed by retrospective and finite element biomechanical analysis. Journal of Orthopaedic Surgery and Research. 10(1). 10–10. 21 indexed citations

19.

Zhu, Zhenqi, et al.. (2014). [Establishment and validation of normal human L1-L5 lumbar three-dimensional finite element model].. PubMed. 94(37). 2919–22. 1 indexed citations

20.

Wang, Jiefu, et al.. (2007). Approach Algorithm Research and Theorem Proof Based on Quadratic B-Spline Curves. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact